๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cancer Risk

Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site๐Ÿ“ Durham Duke University Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites๐Ÿ“ Fort Myers๐Ÿ“ Indianapolis๐Ÿ“ Cleveland Frantz Viral Therapeutics, LLC ยท Tests: Artesunate ointment, Placebo ointment Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma NCT02605421Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Thiotepa, Cyclophosphamide, Melphalan, Etoposide, Carboplatin Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) NCT05686434Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Osimertinib Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia NCT06184009Phase 29 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Incheon Jae Wook Lee ยท Tests: ALL, High risk Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma NCT05595408n/a1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Adjuvant chemotherapy, adjuvant immunotherapy Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation? NCT06777017n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study NCT07059104n/a1 site๐Ÿ“ Gothenburg Vastra Gotaland Region ยท Tests: Breast augmentation, Breast reconstruction after mastectomy Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085Phase 3231 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage Children's Oncology Group ยท Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan A Study of Breast Cancer Risk Factors and Outcomes of People in Florida NCT06780176n/a3 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Biospecimen Collection, Surgical Tissue Collection, Survey Collection A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma NCT03516617Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Acalabrutinib, Laboratory Biomarker Analysis, Obinutuzumab, Patient Observation, Quality-of-Life Assessment Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients NCT06722599n/a1 site๐Ÿ“ Beijing Shu Wang Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus NCT05918510n/a1 site๐Ÿ“ Rome Regina Elena Cancer Institute ยท Tests: Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx SRT Versus SRT+ADT in Prostate Cancer NCT05019846Phase 31 site๐Ÿ“ Brescia Marco Lorenzo Bonu ยท Tests: Triptorelin Embonate, Bicalutamide 50 mg Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening NCT05447169n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: EBV antibodies test, EBV DNA test Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623NA1 site๐Ÿ“ Shanghai Changhai Hospital ยท Tests: Immediate postoperative chemotherapy A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites๐Ÿ“ Bakersfield๐Ÿ“ New Brunswick๐Ÿ“ Myrtle Beach Merck Sharp & Dohme LLC ยท Tests: MK-3120 Early Intervention in High Risk CCUS NCT06802146EARLY Phase 11 site๐Ÿ“ Boston Lachelle D. Weeks, MD, PhD ยท Tests: Inqovi Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma NCT06721286Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Teripalimab, Gemcitabine + Cisplatin, Surgery A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Urine biomarker -Guided without reTURBT Comparing PP and PVDF Meshes in Midline Laparotomy Closure for High-risk Colorectal Surgery. Impact on Incisional Hernia and Surgical Wound Infection. NCT06220045NA1 site๐Ÿ“ Girona Institut d'Investigaciรณ Biomรจdica de Girona Dr. Josep Trueta ยท Tests: Polyvinylidene fluoride mesh, Prophylactic polypropylene mesh Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site๐Ÿ“ Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors NCT00870129NA1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: MRI and advanced MRI sequences DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma NCT04696029Phase 226 sites๐Ÿ“ Little Rock๐Ÿ“ Oakland๐Ÿ“ Sacramento Giselle Sholler ยท Tests: Difluoromethylornithine Akershus Cardiac Examination (ACE) 5 Study NCT07301489NA1 site๐Ÿ“ Lรธrenskog University Hospital, Akershus ยท Tests: Lung Cancer Screening Plus Program, Standard of Care Effect of Honey For CIN II NCT06219018Phase 1, Phase 22 sites๐Ÿ“ Heerlen๐Ÿ“ Maastricht Zuyderland Medisch Centrum ยท Tests: Medical grade honey formulation (MGH) (L-Mesitranยฎ)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy